Showing results (101-110 of 124) with videos related to
Sort By:
Pageof 13
Cancers|July 20, 2021
Gastrointestinal Manifestations in Systemic Mastocytosis: The Need of a Multidisciplinary ApproachMagda Zanelli, Marco Pizzi, Francesca Sanguedolce, et al.Leukemia & Lymphoma|September 8, 2011
Cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab versus epirubicin, cyclophosphamide, vinblastine, prednisone and rituximab for the initial treatment of elderly "fit" patients with diffuse large B-cell lymphoma: results from the ANZINTER3 trial of the Intergruppo Italiano LinfomiFrancesco Merli, Stefano Luminari, Giuseppe Rossi, et al.F1000Research|June 7, 2018
Spatial intratumoural heterogeneity in the expression of GIT1 is associated with poor prognostic outcome in oestrogen receptor positive breast cancer patients with synchronous lymph node metastasesIbai Goicoechea, Ricardo Rezola, María Arestin, et al.Genes|September 23, 2022
Fragile X Syndrome Caused by Maternal Somatic Mosaicism of FMR1 Gene: Case Report and Literature ReviewMaria Jose Gómez-Rodríguez, Montserrat Morales-Conejo, Ana Arteche-López, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 21, 2013
Rituximab maintenance compared with observation after brief first-line R-FND chemoimmunotherapy with rituximab consolidation in patients age older than 60 years with advanced follicular lymphoma: a phase III randomized study by the Fondazione Italiana LinfomiUmberto Vitolo, Marco Ladetto, Carola Boccomini, et al.JAMA Oncology|January 13, 2018
Comparing Neoadjuvant Nab-paclitaxel vs Paclitaxel Both Followed by Anthracycline Regimens in Women With ERBB2/HER2-Negative Breast Cancer-The Evaluating Treatment With Neoadjuvant Abraxane (ETNA) Trial: A Randomized Phase 3 Clinical TrialLuca Gianni, Mauro Mansutti, Antonio Anton, et al.NPJ Genomic Medicine|January 17, 2025
Germline structural variant as the cause of Lynch Syndrome in a family from EcuadorGemma Llargués-Sistac, Laia Bonjoch, Jenifer Muñoz, et al.ACS Infectious Diseases|September 14, 2016
Identification of Novel Anti-mycobacterial Compounds by Screening a Pharmaceutical Small-Molecule Library against Nonreplicating Mycobacterium tuberculosisThulasi Warrier, Maria Martinez-Hoyos, Manuel Marin-Amieva, et al.Cancers|November 27, 2024
Should We Offer Universal Germline Genetic Testing to All Patients with Pancreatic Cancer? A Multicenter StudyJoan Llach, Irina Luzko, Julie Earl, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2017
Long-Term Follow-Up of the Intergroup Exemestane StudyJames P Morden, Isabel Alvarez, Gianfilippo Bertelli, et al.Pageof 13